News

The Pharma Letter1h
The week in pharma: action, reaction and insight – week to July 25
Last week, a US Food and Drug Administration (FDA) advisory committee (AdCom) voted against approval of Danish drugmaker ...
The Pharma Letter21h
FDA delays review of Bayer’s elinzanetant NDA
The US Food and Drug Administration (FDA) has notified Bayer that it has extended the review period for the New Drug ...
The Pharma Letter21h
AstraZeneca’s Cristian Massacesi joins BMS executive team
US pharma major Bristol Myers Squibb revealed it has appointed Dr Cristian Massacesi as executive vice president, chief ...